How to use the speech recognition tool?

VITAL

VITAL

Prospective study of visual function in USHER syndrome induced by MYO7A mutation and retinotosis pigmentosa.

Type: Observational



Status of the trial: Unknown

Orphan Drug Recognition: NA

Inclusion

  • Opening Date: 2017-11-03
  • Closing Date: 2019-11-04

Criteria

Inclusion: USH1B group: genotype with two pathogenic mutations of the MYO7A gene RP group: a genotype with a pathogenic mutation identified. For all: Diagnosis of confirmed retinopathy pigmentosa

Exclusion: Persons who have previously participated in a clinical trial of gene therapy or with ocular disease or ocular opacity. History of amblyopia

Children: Yes

Adults: Yes

Funder Type: industry, public

HCP: Other investigators


Within ERN-EYE members

Principal investigators




Other investigators

Workgroups

  • Retinal Rare Eye Diseases (WG1)

Subscribe to our mailing list

* indicates required

This ERN is supported by: